Cytori Therapeutics Inc Warrant
CYTXW
CYTXW was delisted on the 14th of December, 2018.
3 hedge funds and large institutions have $461K invested in Cytori Therapeutics Inc Warrant in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
25% less funds holding
Funds holding: 4 → 3 (-1)
40% less capital invested
Capital invested by funds: $769K → $461K (-$308K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$357 |
Top Sellers
CYTXW Hedge Fund Activity: Q2 2017 in Review
3 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Warrant (CYTXW) for Q2 2017, worth a combined $461K — down 40% from $769K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CYTXW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Sabby Management, adding an estimated $357.
- 3 institutional investors held Cytori Therapeutics Inc Warrant (CYTXW) as of Q2 2017, down from 4 in Q1 2017.
- Funds reported $461K of Cytori Therapeutics Inc Warrant stock for Q2 2017, down 40% quarter-over-quarter.
- 0 funds opened new Cytori Therapeutics Inc Warrant positions in Q2 2017 and 1 closed out, a net change of -1 holder.
- The largest Cytori Therapeutics Inc Warrant buyer in Q2 2017 was Sabby Management, an estimated $357 added.
Based on aggregated 13F filings for Q2 2017.